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Abstract
AIM: To study the criteria for self-reported dietary 
fructose intolerance (DFI) and to evaluate subjective 
global assessment (SGA) as outcome measure.
METHODS: Irritable bowel syndrome (IBS) patients 
were randomized in an open study design with a 2 
wk run-in on a habitual IBS diet, followed by 12 wk 
with/without additional fructose-reduced diet (FRD). 
Daily registrations of stool frequency and consistency, 
and symptoms on a visual analog scale (VAS) were 
performed during the first 4 wk. SGA was used for 
weekly registrations during the whole study period. 
Provocation with high-fructose diet was done at 
the end of the registration period. Fructose breath 
tests (FBTs) were performed. A total of 182 subjects 
performed the study according to the protocol (88 
FRD, 94 controls).
RESULTS: We propose a new clinically feasible dia-
gnostic standard for self-reported fructose intolerance. 
The instrument is based on VAS registrations of symptom 
relief on FRD combined with symptom aggravation upon 
provocation with fructose-rich diet. Using these criteria 43 
of 77 patients (56%) in the present cohort of IBS patients 
had self-reported DFI. To improve the concept for clinical 
evaluation, we translated the SGA scale instrument to 
Norwegian and validated it in the context of the IBS diet 
regimen. The validation procedures showed a sensitivity, 
specificity and κ value for SGA detecting the self-reported 
DFI group by FRD response within the IBS patients of 0.79, 
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0.75 and 0.53, respectively. Addition of the provocation 
test yielded values of 0.84, 0.76 and 0.61, respectively. 
The corresponding validation results for FBT were 0.57, 
0.34 and -0.13, respectively.
CONCLUSION: FRD improves symptoms in a subgroup 
of IBS patients. A diet trial followed by a provocation 
test evaluated by SGA can identify most responders to 
FRD.
Key words: Breath test; Dietary restriction; Fructose 
malabsorption; Functional bowel disease; Sugar intolerance
© The Author(s) 2015. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: In this second report from the FINN study, 
new diagnostic criteria for self-reported fructose 
intolerance, based on fructose-reduced diet (FRD), were 
developed. Subjective global assessment of abdominal 
relief seems to be a valid outcome measure, which may 
be used as a feasible alternative to daily visual analog 
scale registrations both in daily routine handling of 
these patients and in future studies of irritable bowel 
syndrome (IBS). More than half of IBS patients in this 
study seemed to benefit from using FRD to control their 
IBS symptoms.
Berg LK, Fagerli E, Myhre AO, Florholmen J, Goll R. Self-
reported dietary fructose intolerance in irritable bowel syndrome: 
Proposed diagnostic criteria. World J Gastroenterol 2015; 
21(18): 5677-5684  Available from: URL: http://www.wjgnet.
com/1007-9327/full/v21/i18/5677.htm  DOI: http://dx.doi.
org/10.3748/wjg.v21.i18.5677
INTRODUCTION
The self-reported intolerance to fructose intake has 
been described as fructose malabsorption (FM) due to 
small intestinal dysfunction. This was first reported in 
four patients with chronic diarrhea and colic in 1978[1], 
in healthy subjects in 1983[2], and in populations with 
irritable bowel syndrome (IBS) in 1986[3]. Fructose 
is absorbed from the intestinal lumen by facilitated 
diffusion through the GLUT5 transporter protein in 
the mucosa, which is a type of glucose-dependent 
transport[4]. The exact mechanisms leading to 
incomplete fructose absorption are unknown, and in 
the literature, they are described as ranging from a true 
condition to a variance of normality[5]. Moreover, it is 
well established that factors such as dietary sorbitol[6,7] 
and dietary non-hydrolysable fructans[8] aggravate IBS 
symptoms[9]. The amount of sorbitol needed to provoke 
IBS symptoms appears to be ≥ 10 g[10].
The current diagnostic test for FM, the fructose breath 
test (FBT), is suboptimal due to the many variations in 
the normal capacity of fructose absorption[5]. There are 
numerous factors that give false-negative and false-
positive results, as reviewed by Kyaw and Mayberry[5]. 
These include factors such as colonization by non-
hydrogen-producing bacteria and gastrointestinal 
dysmotility[5]. In a recently published report we have 
described a discrepancy between the FBT and the effects 
of a fructose-reduced diet (FRD)[11].
Due to the lack of an accurate and valid test for 
diagnosing FM, there is an increasing interest to use self-
reported responses to FRD as a diagnostic tool for FM. 
Goldstein et al[6] reported that in patients with IBS or 
functional abdominal complaints, 56%-60% improved 
their symptoms when on a low-fructose diet; a finding 
also reported in some observational studies[12-14]. 
Therefore, as advocated by Fernández-Bañares et al[14], 
the use of FRD is a simple and feasible test that should 
be utilized more in clinical practice. So far, there is no 
standardized procedure for performing FRD tests. This 
includes no standardized level for the upper load of 
fructose to be used per meal, as well as a lack of a clinical 
tool to assess the effects of FRD in IBS patients.
The aims of the present study were: (1) to define 
criteria for self-reported dietary fructose intolerance 
(DFI) in a cohort of patients with IBS defined by 
Rome Ⅱ criteria; and (2) to evaluate subjective global 
assessment (SGA) registration as an alternative to a 
diary-based symptom registration (VAS scale) as an 
outcome measure. This is a follow-up report of the 
open multicenter randomized controlled trial, Fructose 
Malabsorption in Northern Norway[11].
MATERIALS AND METHODS
Enrolment and patient flow 
The study outline has been published earlier[11]. In 
brief, during the period July 2008 and July 2011, 
patients who met the Rome Ⅱ criteria for diagnosis 
were recruited. The IBS patients were registered 
according to their subtypes: constipation or diarrhea. 
An individual diagnostic workup was performed 
including, but not mandatory, blood tests, stool 
samples, breath tests, endoscopy and histological 
examination, and X-ray or ultrasound investigations 
to ensure the exclusion of organic disease or other 
malabsorption diseases such as lactose intolerance or 
celiac disease. Exclusion criteria were patients with 
severe chronic disease, severe chronic constipation 
(defined as laxative users), patients taking antibiotics 
or nonsteroidal anti-inflammatory drugs (NSAIDs), 
and patients whom had previously had performed an 
FBT or used an FRD.
Study design
As previously described[11], the study was designed 
with a pre-registration period of 2 wk in which the 
patients followed their individual habitual IBS diet 
(HID). The patients were then randomized without 
stratification to continue HID with or without additional 
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FRD (< 2 g fructose per meal) for 12 wk.
The randomization was assisted by The Scientific 
Department, University Hospital of North Norway, 
Tromsø.
Individual instructions for the FRD were given both 
verbally and through written information that included 
a table in Norwegian showing the fructose content in 
91 common food ingredients (a similar table can be 
found at web site given in reference 15). For a short 
version of the table of instructions see Table 1.
In addition to daily VAS registrations of abdominal 
pain/discomfort, bloating, stool frequency and 
consistency for 4 wk, an SGA registration was 
completed once weekly for 12 wk. Early dropouts 
(defined as patients who registered for < 3 wk of the 
main 12-wk period) were replaced but late dropouts 
were not replaced. Data from patients that registered 
for > 3 of the 4 wk were included in the total 
registration. The main reason for choosing a 4-wk VAS 
registration was concern about compliance because 
the subject would have to perform daily registrations 
throughout the study. After the main registration 
period, the patients delivered their diaries, underwent 
FBT, and were instructed in the fructose-rich 
provocation test for a maximum of 7 d, or for a shorter 
time if the test provoked IBS symptoms. For the 
provocation test, patients were told to choose sucrose-
rich food and to include ≥ 200 mL of fruit juice with 
only small amounts of sorbitol in each daily meal[15,16] 
(e.g., 200 mL orange juice, 8-9 g fructose with no 
sorbitol content/200 mL apple juice, 15 g fructose and 
1 g sorbitol). Study patients were instructed to use the 
same information table as a guide for both reducing 
fructose load and ensuring a sufficient intake of 
fructose (30 g) during the provocation test[15]. The VAS 
and SGA scores (as compared to the last week of main 
registration)[11] were logged in a separate provocation 
diary.
Symptom score of IBS
The subjects filled in a symptom registration diary. 
Each day they marked on a VAS form (0-100 mm) the 
degree of pain and bloating experienced (0 mm for no 
symptoms, and 100 mm for maximal symptom score). 
In addition, they counted the number of stools and 
gave a description of the stool quality on a scale of 1-7 
(Bristol scale)[13].
Self reported fructose intolerance: Diagnostic criteria
Based on the experiences from our first study[11], a 
diagnostic test based on a self-reported (subjective) 
intolerance to fructose in IBS was constructed. 
We defined fructose-related food intolerance as a 
combination of symptom relief associated with dietary 
fructose restriction and symptom exacerbation following 
a fructose provocation test. In our previous study[11] 
the Bland-Altman analysis showed that the technical 
detection limits (corresponding to 1.96 SD of mean 
bias) were 18 mm (18% on VAS scale of 100 mm) 
for pain/discomfort and 17 mm for bloating. Based on 
these boundaries a response to FRD was defined as 
> 25 mm relief, whereas > 25 mm worsening of the 
VAS score during provocation was considered a positive 
test[11].
SGA score of IBS
Patients determined the SGA of abdominal relief 
once during every weekend of the study period by 
entering their assessment in their personal diary. The 
assessment was completed by answering the following 
question: Please consider how you have felt the past 
week with regards to your IBS, in particular your 
overall wellbeing, symptoms of abdominal discomfort, 
pain and altered bowel habit compared to how you 
felt before entering the study). How do you rate your 
relief (or worsening) of symptoms during the past 
week? The scale contained five possible answers: (1) 
completely relieved; (2) considerably relieved; (3) 
somewhat relieved; (4) unchanged; or (5) worse[17]. 
Using the SGA score, patients who were somewhat 
relieved in week 3 and 4, or completely/considerably 
relieved in at least 1 wk were considered to have 
responded to the FRD.
Breath tests
Hydrogen (H2) and methane (CH4) were measured 
by a Microlyzer (Quintron Instrument Co. Inc., 
Milwaukee, WI, United States) in end-expiratory 
breath samples. After an overnight fast, H2 and CH4 
levels were measured before drinking 15 mL solution 
corresponding to 50 g fructose). Measurements were 
performed every 30 min until a gas peak was reached, 
Berg LK et al . Fructose intolerance in IBS
Table 1  Fructose-reduced diet (according to definition < 2 
g fructose/meal)




All other types of 
fruit and berries
Vegetables Most vegetables, 
avocado




100% ground beef 

















 Bread, pasta, rice 
and white flour
Sweet bakery and 
cereals





Drinks Water, milk, tea, 
coffee, light soda 




Juice, nectar, sodas 
and fructose
drinks, milk with 
sugar or fructose 
added
Table 2  Demographic and baseline variables for patients 
included
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or up to 4 h. A high load of fructose was used to 
minimize false-negative results as indicated by Choi 
et al[12]. Incomplete absorption was defined as an 
increase of H2 > 20 ppm or CH4 > 12 ppm, or a sum of 
combined peak increase > 15 ppm. Symptoms during 
and after the test were recorded.
Statistical analysis and validation
The statistical analysis included all randomized patients 
(intention to treat). Patients where split into the two 
predefined groups according to the study protocol; 
either a normal IBS diet alone or combined with 
FRD. A test-retest analysis of SGA was performed by 
comparing scores at pre-registration with those at 
1, 4 and 12 wk in the control group; ∆ values were 
run using a Wilcoxon signed rank test vs 0. Internal 
consistency was explored by analysis of variance 
(ANOVA) and Spearman’s correlation on ∆VAS (week 
0 vs week 4) vs SGA score at 4 wk in all included 
patients. The former analysis also yielded information 
regarding scale linearity and precision of the SGA 
measure. Finally, the face validity denoting whether 
the questions made sense was performed in all of the 
patients and 10 healthy volunteers.
RESULTS
Enrollment of patients
Patient inclusion in this multicenter study is described 
in detail in a previous publication[11]. In brief, 310 
patients admitted to hospital with IBS symptoms were 
screened, and 108 did not meet the inclusion criteria. 
The 202 patients included were randomized, and 182 
completed the main registration period of 12 wk. All 
early dropouts were replaced. All patients reported a 
combination of constipation and diarrhea. A total of 88 
patients were randomized to FRD. Among these, we 
experienced missing data from 11 patients; nine due 
to a missing provocation diary and two that missed 
markings for SGA change in week 4 of the main diary. 
The remaining 77 patients reported complete VAS and 
SGA data both during the pre- and main registration 
periods, as well as a complete registration during the 
provocation test. We found no significant differences 
in age, sex ratio, abdominal pain/discomfort, bloating, 
stool frequency or Bristol scale stool consistency 
between the FRD + HID and HID groups (Table 2).
Validation analysis of SGA
Internal consistency was tested by calculating the VAS 
change for each of the 182 patients by comparing 
status at 4 wk with pre-registration. These ∆ values 
were compared to SGA scores at week 4 using the 
Spearman Rank correlation test. The analysis yielded ρ 
values of 0.59 (SGA vs pain/discomfort, P < 0.0005); 
0.58 (SGA vs bloating, P < 0.0005); and 0.84 (bloating 
vs pain/discomfort, P < 0.0005). The graph for the 
control group illustrated in Figure 1 shows that SGA is 
a stable measure throughout the 3-mo study period. 
A test-retest analysis was performed by analyzing the 
control group SGA values in pairs. For each record, 
the differences between pre-registration week 0 and 
weeks 1, 4 and 12 were calculated. These delta values 
were analyzed with a Wilcoxon signed rank test using 
zero as the median for the null-hypothesis. The three 
∆ values were not significantly different from zero (P 
= 0.41, 0.13, and 0.42 for pre-registration vs week 1, 
4, and 12, respectively). Figure 1 shows the raw data 
distribution of VAS change registrations in the five SGA 
categories at 4 wk for all 182 study participants. The 
SGA scale is not linear; it discriminates best between 
the span of somewhat relieved and towards completely 
relieved. Two-way ANOVA of this dataset (VAS by SGA 
× Diet group) was performed and pairwise comparison 
is presented in Table 3. The traces for the control 





Age, yr (median 
range)
     43 (18-73)      46 (19-73)      43 (18-73) NS1
Female/male ratio (%) 61/16 25/9 36/7 NS2
Abdominal pain/
discomfort (mm)
    53(3-89)    58 (3 89)      50 (16-76) NS1
Bloating (mm)      55 (20-84)      58 (22-83)      54 (20-84) NS1
Stool frequency 
[median (range)]
1.5 (0-4) 1.6 (1-4) 1.5 (0-4) NS3
Boston scale stool 
consistency
4.4 (1.9-6.0) 4.6 (1.9-6.0) 4.3 (2.6-5.9) NS1
1Independent samples t-test; 2The χ 2 test; 3Mann-Whitney U. IBS: Measures 
are mean preregistration values (95%CI) unless otherwise stated. 
Treatment group differences were tested. SRFI: Self reported fructose 
intolerance; NS: Not significant. 
Figure 1  Scale and precision of the subjective global assessment measure. 
At 4 wk, the change in VAS registration (compared to pre-registration values) was 
calculated. Box and whiskers plot of VAS change in the different subcategories of 
SGA at 4 wk. It is noted that the scale is not entirely linear, with best discrimination 
in the left part of the plot, while the right part shows smaller VAS differences 
between groups. SGA: Subjective global assessment; VAS: Visual analog scale.



























Four week SGA Pain/discomfort
Bloating
Table 4  Testing new diagnostic criteria of self-reported 
fructose intolerance in irritable bowel syndrome (for 
definition, see text) against fructose breath test and response 
of subjective global assessment test
Table 3  Pairwise comparisons of visual analog scale readings by ANOVA
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group in Figures 2 and 3 show that the VAS measure 
and the SGA rating were stable over time when used 
in an IBS setting.
As shown in Table 4, for SGA, there was good 
sensitivity and specificity of 0.84 and 0.74, respectively, 
for identifying self-reported DFI. The inclusion of a 
provocation test in the diagnostic criteria improved 
the quality of the test criteria; especially the negative 
predictive value (Table 4). The sensitivity and 
specificity parameters for the FBT were low (Table 4). 
Self-reported DFI: Agreement with breath tests
Using our new criteria for the diagnosis of self-reported 
DFI, we established a diagnostic tool for fructose 
intolerance based on the results from the agreement 
testing (frequency analysis) (Table 4). As described in 
our earlier report[11], a discrepancy was found between 
the self-reported fructose intolerance and FBT. This was 
confirmed in the frequency analysis that gave a κ value 
of -0.13. There was a good agreement between the 
diagnosis of self-reported DFI and the SGA responses 
to FRD according to the criteria used (see methods) 
with a κ value of 0.61 (Table 4). When results from the 
provocation test were excluded from the diagnostic 
criteria, the κ value was less precise (κ  = 0.53).
Prevalence of self-reported fructose intolerance
The prevalence of self-reported fructose intolerance, 
defined as a combination of response to FRD and a 
positive provocation test, was 56% (43 of 77 patients). 
DISCUSSION
In this open label, unstratified, randomized multicenter 
study of FRD in patients with IBS, we proposed new 
diagnostic criteria for FM based on the combination 
of effects from FRD and a positive provocation test. 
This is based on symptom registration (using a VAS 
scale) as the outcome measure. The FBT shows 
poor characteristics for identifying these patients. An 
alternative SGA registration, as an outcome measure 
for FRD, showed a good agreement with the new 
diagnostic criteria. Our study opens a new approach 
in the management of DFI in IBS patients. A fructose-
restricted diet of < 2 g fructose per meal, together with 
a standardized method for SGA registration, can be used 
as the first step in the management of IBS patients in 
clinical practice. Using these new diagnostic criteria, the 
prevalence of self-reported fructose intolerance in the 
IBS cohort admitted to a gastroenterology unit was as 
high as 56%.
In this study, the criteria for the diagnosis of fructose 
intolerance are based on self-reported symptoms 
of relief, whilst on FRD, and symptom aggravation 









VAS bloating Adj R 2 = 0.47 VAS pain/discomfort Adj R 2 = 0.46
Unchanged vs Completely relieved 46.1 ± 6.1 < 0.0005 Unchanged vs Completely relieved 41.1 ± 5.5 < 0.0005
Considerably relieved 23.5 ± 3.0 < 0.0005 Considerably relieved 20.8 ± 2.7 < 0.0005
Somewhat relieved   7.6 ± 2.8  0.066 Somewhat relieved   5.9 ± 2.5  0.202
Worse  -7.4 ± 3.3  0.275 Worse  -9.4 ± 3.0  0.024
Results for two-way ANOVA: VAS by SGA × Diet. Mean differences in VAS change of SGA categories compared to unchanged, adjusted for diet type. P 
values were adjusted by Bonferroni correction. SGA: Subjective global assessment; VAS: Visual analog scale.







FBT 0.57 0.34 0.58 0.29 -0.13
SGA weeks 3-41 0.79 0.75 0.82 0.71  0.53
SGA week 3-42 0.84 0.76 0.83 0.79  0.61
1Without result provocation; 2With result provocation. SGA: Subjective 







-2         0          2          4         6          8         10         12
Effect of FRD
t /wk
Figure 2  Subjective global assessment of irritable bowel syndrome-
related symptoms during the whole study. Mean registration (95%CI) 
for study groups. The control group showed stable mean value during the 2 
+ 12 wk registration. The mean effect of FRD was marked, showing stable 
improvement of symptom rating during the whole study. The SGA ratings 
were: 1: Completely relieved; 2: Considerably relived; 3: Somewhat relieved; 
4: Unchanged; 5: Worse. FRD: Fructose-reduced diet; SGA: Subjective global 
assessment; IBS: Irritable bowel syndrome.
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following a fructose provocation test.
This was chosen due to the lack of a more precise 
or accurate objective test, including breath tests[5]. 
The international consensus of nomenclature for food-
related disorders from 2001[18] defines self-reported 
fructose intolerance as a nonallergic hypersensitive 
reaction to fructose-rich food items. Moreover, the 
concept of self reporting is a descriptive term based on 
patient registration of symptoms[19]. In other reports 
of food-related disorders in which objective diagnostic 
tests were lacking, the patient’s symptoms were 
referred to as subjective[20] or perceived[21].
In this study, we used SGA as a clinical tool to 
assess the effects of FRD. A translated modification of 
a 5-degree scoring system of a validated questionnaire 
for IBS, described by Müller-Lissner et al[17], was 
performed. The validation of the Norwegian translation 
of SGA, used in IBS patients on an FRD, showed good 
agreement with VAS measures - and in particular, the 
categories completely relieved and considerably relieved 
indicated a substantial change in VAS recordings. The 
scale is not linear, and the VAS recordings do not as 
clearly differentiate between the category transitions 
somewhat relieved-unchanged and unchanged-worse.
Considering our earlier study on VAS recordings 
for this patient group, these transitions represent 
VAS differences that are lower than the technical 
discrimination limits of 17 and 18 mm for bloating 
and pain/discomfort, respectively[11]. In contrast, 
the categories completely relieved and considerably 
relieved both represent a mean VAS change above the 
technical discrimination limit. Thus, a single SGA rating 
should reliably identify an improvement in symptoms 
when rated as completely relieved or considerably 
relieved. The test-retest analysis showed no significant 
time-related bias, which was also demonstrated in the 
graph for the control group in Figure 3. Face validity 
was evaluated in healthy volunteers, and revealed no 
problems in the interpretation of the questions. Finally, 
good sensitivity and specificity for identifying self-
reported DFI was found for SGA.
According to the proposed diagnostic criteria, the 
prevalence of self-reported fructose intolerance in a 
cohort of IBS patients admitted to a gastrointestinal 
unit was 56%. Among the few studies reporting the 
prevalence of FM, defined according to FBT, Goldstein 
et al[6] reported that 44% of patients with IBS or 
functional abdominal complaints had the condition.
This was based on a consumption of 50 g fructose 
and 56%-60% improved on a low-fructose diet[6], 
whereas Barrett et al[22] found FM as high as 34% in 
healthy volunteers. Finally, in the recently published 
FODMAP diet studies, representing a diet reduced in 
fructose and other carbohydrate types, about 50% of 
the IBS patients improved their symptoms and VAS 
scores[23]. Our prevalence data must be interpreted 
with some caution. Including only those who reported 
complete relief of their symptoms by FRD, the 
prevalence was reduced to about 20%. Moreover, based 
on the individual normal variation for the capacity of 
fructose absorption[5], the prevalence of self-reported 
fructose intolerance in IBS has to be compared with 
the reference population, including potential factors 
such as genetics and the fructose content in daily food 
intake.
The strength of this study was that we performed 
a prospective randomized study with validation of the 
SGA as a tool for assessing IBS-related symptoms 
during dietary treatment. The FBT was performed after 
12 wk observation, which prevented potential bias 
during registration of symptoms.
There were some limitations to the study. First, 
the intervention could not be blinded for obvious 
reasons. Second, a more exact diary registration of 
the amount of fructose, glucose, and sorbitol intake in 
each meal during the FRD[7], could have given valuable 
information. Finally, based on our knowledge of 
normal variations with regards to fructose absorption 
capacity[5], a more detailed background registration of 
the fructose/sucrose content in the daily food intake of 
the IBS patients and in the reference population would 
have given more comprehensive data.

















Figure 3  Visual analog scale registrations of irritable bowel syndrome-
related symptoms during the first 2 + 4 wk. Mean registration (95%CI) for 
the study groups. FRD: Fructose-reduced diet; VAS: Visual analog scale; IBS: 
Irritable bowel syndrome.
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been observed in the past 20 years. During the same 
period, consumption of fructose as well as processed 
food and additives has increased in the general 
population[24]. It is tempting to speculate that the 
increased fructose ingestion may explain the observed 
increase in IBS. If so, an FRD could be an appropriate 
option for diagnosis and treatment of patients with 
IBS. If this diet induces symptom relief, according to 
SGA registrations, a subsequent simple provocation 
test, two glasses of fruit juice with low sorbitol content 
at each meal, in combination with an augmented 
intake of fructose-rich food, could be performed.
New diagnostic criteria for self-reported fructose 
intolerance, based on FRD are proposed. SGA appears 
to be a valid outcome measure, which is a feasible 
alternative to daily VAS registrations; both in daily 
routine management of these patients and for future 
studies of IBS.
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A substantial increase in the prevalence of irritable bowel syndrome (IBS) 
has been observed in the past 20 years. The main symptoms of IBS include 
abdominal pain, bloating, diarrhea or constipation. During the same period, 
an increase in the consumption of fructose, as well as processed food and 
additives has been seen in the general population. Fructose intolerance is 
regarded as a subgroup of IBS, and it has been proposed that the increase in 
IBS actually represents fructose intolerance as a result of the increased intake 
of this sugar. In the recently published FODMAP diet studies, which consist of 
a diet reduced in fructose and other carbohydrate types, about 50% of the IBS 
patients are reported to improve their symptoms and visual analog scale (VAS) 
score.
Research frontier
The self-reported intolerance to fructose intake has been described as fructose 
malabsorption (FM) due to small intestinal dysfunction. This was first reported 
in four patients with chronic diarrhea and colic in 1978. Despite later extensive 
studies the mechanisms behind this disease or medical condition are still 
unknown. One of the main unresolved problems is whether fructose intolerance 
is due to an overload of fructose intake and/or a defect in fructose absorption 
from the intestinal lumen.
Innovation and breakthroughs
Last year the authors published a report from the study Fructose malabsorption 
in Northern Norway (FINN study) in which the fructose breath test - the only 
objective test of FM - correlated poorly with self-reported fructose intolerance 
among IBS patients. In this second report from the FINN study, Subjective 
Global assessment of abdominal relief (subjective global assessment) was 
shown to be a valid end-point measure. This report also shows that a high 
dietary fructose load is the main explanation for this disease.
Applications
Validated end-point measures are necessary tools for future studies of self-
reported fructose intolerance.
Terminology
Fructose intolerance is defined as a self-reported intolerance to a normal load 
of fructose intake. FM is a similar concept, but mainly based on the abnormal 
intestinal absorption of fructose measured by FBT. The two concepts are used 
interchangeably in the literature and most likely describe the same medical 
condition.
Peer-review
Although the findings of this study replicate commonsense practice, this is 
a useful addition to literature in these days of evidence-based medicine. 
The sequence the authors followed is historically what happened with the 
lactose-intolerance studies, where the focus shifted from mucosal lactase 
measurements to lactose tolerance curves to symptom analysis
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